Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. Summary
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
184.9(c) 189.5(c) 196.7(c) 197.7(c) 197.3(c) Last
71 480 61 865 78 978 55 698 53 852 Volume
+0.05% +2.49% +3.80% +0.51% -0.20% Change
More quotes
Estimated financial data (e)
Sales 2021 289 M 45,1 M 45,1 M
Net income 2021 -1 125 M -176 M -176 M
Net cash position 2021 659 M 103 M 103 M
P/E ratio 2021 -7,26x
Yield 2021 -
Sales 2022 479 M 74,7 M 74,7 M
Net income 2022 -1 036 M -162 M -162 M
Net cash position 2022 504 M 78,7 M 78,7 M
P/E ratio 2022 -8,76x
Yield 2022 -
Capitalization 8 556 M 1 334 M 1 334 M
EV / Sales 2021 27,3x
EV / Sales 2022 16,8x
Nbr of Employees 360
Free-Float 99,3%
More Financials
Company
Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and... 
More about the company
Ratings of Zealand Pharma A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ZEALAND PHARMA A/S
10/13European ADRs Move Higher in Wednesday Trading
MT
10/06European ADRs Move Lower in Wednesday Trading
MT
10/01ZEALAND PHARMA A/S : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION (Form 6-..
PU
09/30European ADRs Move Higher in Thursday Trading
MT
09/29European ADRs Move Higher in Wednesday Trading
MT
09/27European ADRs Move Higher in Monday Trading
MT
09/21European ADRs Move Higher in Tuesday Trading
MT
09/10ZEALAND PHARMA A/S : Transactions in Zealand Pharma sharesáand/or related securities by pe..
AQ
09/10ZEALAND PHARMA A/S : increases its share capital as a consequence of exercise of employee ..
AQ
09/09Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependen..
GL
09/09Zealand Pharma A/S Presents Data At 2021 ESPEN Virtual Congress Demonstrating Dose-Depe..
CI
09/07ZEALAND PHARMA A/S : Transactions in Zealand Pharma sharesáand/or related securities by pe..
AQ
09/07ZEALAND PHARMA A/S : New Employee Elected Director to the board of Zealand Pharma A/S (For..
PU
09/03European ADRs Move Lower in Friday Trading
MT
09/03ZEALAND PHARMA A/S : to Participate in Morgan Stanley 19th Annual Global Healthcare Confer..
AQ
More news
News in other languages on ZEALAND PHARMA A/S
10/13Les ADR européens sont en hausse mercredi
10/06Les ADR européens en baisse mercredi
09/30Les ADR européens sont en hausse jeudi
09/29Les ADR européens sont en hausse mercredi
09/27Les ADR européens en hausse lundi
More news
Analyst Recommendations on ZEALAND PHARMA A/S
More recommendations
Chart ZEALAND PHARMA A/S
Duration : Period :
Zealand Pharma A/S Technical Analysis Chart | ZEAL | DK0060257814 | MarketScreener
Technical analysis trends ZEALAND PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 197,30 DKK
Average target price 236,20 DKK
Spread / Average Target 19,7%
EPS Revisions
Managers and Directors
Emmanuel Dulac President & Chief Executive Officer
Matthew D. Dallas Chief Financial Officer & Senior Vice President
Alf Gunnar Martin Nicklasson Chairman
Adam Sinding Steensberg Chief Medical Officer, EVP-Research & Development
Danilo Verge Head-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
ZEALAND PHARMA A/S-10.56%1 334
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%66 184
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156